Psyence Biomedical PBM Ratios (2023-2026)

NASDAQ PBM
$4.84 +0.10 (+2.11%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Psyence Biomedical Quarterly Ratios

Periods 7 quarters
Latest Mar 2026

Psyence Biomedical ratios data for the quarter ended Mar 2026. These financial ratios cover 7 quarters of results from Mar 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Efficiency
Assets AverageAssets Avg. 130.26M7.14M7.14M1.93M4.78M10.06M15.19M
Invested CapitalInvested Cap. 1.02M1.27M-0.00M
Leverage & Solvency
Interest Coverage RatioInterest Cover -7.30312.20547.67
Debt Ratio 0.160.920.56
Times Interest Earned -7.30312.20547.67
Return Ratios
Return on Assets [ROA]ROA -36.65%